Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

D2G ONCOLOGY, INC.

Group Recipients By:

Issue Date FY Summary


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Award Number	Award Title	Award Code	Budget Year	OPDIV	Action Date	Action Amount

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2021	D2G ONCOLOGY, INC.	353 LOWELL AVE	PALO ALTO	CA	94301-3812	SANTA CLARA	USA	R44CA250672	Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform	000	2	NIH	10/20/2022	$0
															Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $865,070 )
2021	2021	D2G ONCOLOGY, INC.	353 LOWELL AVE	PALO ALTO	CA	94301-3812	SANTA CLARA	USA	R44CA250672	Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform	000	2	NIH	8/26/2021	$865,070
															Subtotal = $865,070

Issue Date FY: 2020 ( Subtotal = $1,134,487 )
2020	2020	D2G ONCOLOGY, INC.	353 LOWELL AVE	PALO ALTO	CA	94301-3812	SANTA CLARA	USA	R44CA250672	Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform	000	1	NIH	9/8/2020	$1,134,487
															Subtotal = $1,134,487

Grand Total All Awards = $1,999,557

Top